Mutual of America Capital Management LLC Decreases Position in Lam Research Corporation $LRCX

Mutual of America Capital Management LLC cut its stake in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 1.7% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 180,391 shares of the semiconductor company’s stock after selling 3,169 shares during the period. Mutual of America Capital Management LLC’s holdings in Lam Research were worth $17,559,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. BankPlus Wealth Management LLC boosted its stake in shares of Lam Research by 2.0% in the second quarter. BankPlus Wealth Management LLC now owns 5,248 shares of the semiconductor company’s stock valued at $511,000 after purchasing an additional 105 shares during the period. ORG Partners LLC boosted its position in Lam Research by 7.3% in the 2nd quarter. ORG Partners LLC now owns 1,676 shares of the semiconductor company’s stock valued at $162,000 after buying an additional 114 shares during the last quarter. Quotient Wealth Partners LLC grew its stake in shares of Lam Research by 2.1% during the second quarter. Quotient Wealth Partners LLC now owns 5,437 shares of the semiconductor company’s stock valued at $529,000 after acquiring an additional 114 shares in the last quarter. Fairvoy Private Wealth LLC increased its position in shares of Lam Research by 3.0% during the second quarter. Fairvoy Private Wealth LLC now owns 4,185 shares of the semiconductor company’s stock worth $407,000 after acquiring an additional 120 shares during the last quarter. Finally, Rosenberg Matthew Hamilton lifted its stake in shares of Lam Research by 16.0% in the second quarter. Rosenberg Matthew Hamilton now owns 869 shares of the semiconductor company’s stock worth $85,000 after acquiring an additional 120 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Citigroup raised their price objective on Lam Research from $113.00 to $120.00 and gave the company a “buy” rating in a research note on Monday, September 8th. Deutsche Bank Aktiengesellschaft raised shares of Lam Research from a “hold” rating to a “buy” rating and raised their price target for the stock from $100.00 to $150.00 in a research report on Monday, September 29th. Barclays set a $83.00 price target on shares of Lam Research and gave the company an “equal weight” rating in a report on Monday, July 28th. UBS Group raised their price objective on shares of Lam Research from $95.00 to $120.00 and gave the stock a “buy” rating in a report on Monday, July 21st. Finally, Mizuho set a $162.00 target price on shares of Lam Research and gave the company an “outperform” rating in a research note on Thursday. Twenty-three analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $125.08.

Read Our Latest Report on LRCX

Insider Transactions at Lam Research

In other news, SVP Vahid Vahedi sold 52,190 shares of the business’s stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 0.31% of the company’s stock.

Lam Research Stock Down 0.6%

Shares of NASDAQ:LRCX opened at $141.51 on Friday. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $153.70. The company’s fifty day moving average is $119.06 and its two-hundred day moving average is $96.94. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21. The stock has a market capitalization of $178.45 billion, a price-to-earnings ratio of 34.02, a price-to-earnings-growth ratio of 1.72 and a beta of 1.84.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.12. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The business had revenue of $5.17 billion during the quarter, compared to the consensus estimate of $4.99 billion. During the same quarter in the prior year, the firm earned $1.03 EPS. The company’s revenue for the quarter was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Equities analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th were paid a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Wednesday, September 24th. This is an increase from Lam Research’s previous quarterly dividend of $0.23. Lam Research’s dividend payout ratio (DPR) is currently 25.00%.

Lam Research Company Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Read More

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.